All In Biotech

Free tool

FAERS Monitor: Timoptic In Ocudose

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019463 or its brand name (Timoptic In Ocudose, Timolol Maleate). Reports on generic versions are filed under their own applications.

Reports

7,686

Serious

3,660

48% of reports

Hospitalization

1,542

Death reported

438

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure979
  • drug ineffective570
  • eye pain437
  • fatigue405
  • eye irritation350
  • dizziness288
  • diarrhoea283
  • off label use261
  • nausea258
  • vision blurred257
  • headache240
  • ocular hyperaemia227
  • death226
  • dyspnoea226
  • intraocular pressure increased224

Reports by year received

View as table
YearReports
2004162
2005192
2006154
2007142
2008136
2009132
2010204
2011219
2012312
2013109
2014133
2015238
2016277
2017329
2018346
2019392
20201,432
2021408
2022438
2023513
2024516
2025557
2026344

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,473 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal22448.842.810,264
treatment failureSignal97932.730.829,829
eye painSignal43721.419.58,415
eye irritationSignal35016.715.15,145
ocular hyperaemiaSignal22713.111.62,529
vision blurredSignal2575.14.5854
dizziness2881.61.462
fatigue4051.41.353
diarrhoea2831.21.110
drug ineffective5701.21.117
dyspnoea2261.11.02
headache2401.00.90
nausea2580.90.83
off label use2610.80.711
death2260.70.626

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.